Newsoara Biopharma Co., Ltd.

This early-phase trial is testing an experimental drug called HY6725 in 74 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo as a single injection or two injections one month apart. The study does not aim to treat…

This early-stage study tests whether a new drug, HY8931, is safe and how the body processes it. Sixty healthy adults aged 18 to 45 will receive either the drug or a placebo. Participants will be monitored for up to 90 days after dosing.